Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Tian Su, Zixing Ding, Lizhen Cui & Lingguo Bu. (2023) System Development and Evaluation of Human–Computer Interaction Approach for Assessing Functional Impairment for People with Mild Cognitive Impairment: A Pilot Study. International Journal of Human–Computer Interaction 0:0, pages 1-15.
Read now
Read now
Alexandre A. de Castro, Flávia V. Soares, Ander F. Pereira, Daniel A. Polisel, Melissa S. Caetano, Daniel H. S. Leal, Elaine F. F. da Cunha, Eugenie Nepovimova, Kamil Kuca & Teodorico C. Ramalho. (2019) Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease. Expert Review of Neurotherapeutics 19:5, pages 375-395.
Read now
Read now
Luca Piemontese, Daniel Tomás, Asha Hiremathad, Vito Capriati, Emanuel Candeias, Sandra M. Cardoso, Sílvia Chaves & M. Amélia Santos. (2018) Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates. Journal of Enzyme Inhibition and Medicinal Chemistry 33:1, pages 1212-1224.
Read now
Read now
Ana Cláudia Santos, Francisco Veiga & António J Ribeiro. (2011) New delivery systems to improve the bioavailability of resveratrol. Expert Opinion on Drug Delivery 8:8, pages 973-990.
Read now
Read now
Linda K McEvoy & James B Brewer. (2010) Quantitative structural MRI for early detection of Alzheimer’s disease. Expert Review of Neurotherapeutics 10:11, pages 1675-1688.
Read now
Read now
Sanghamitra Bandyopadhyay, Xudong Huang, Debomoy K Lahiri & Jack T Rogers. (2010) Novel drug targets based on metallobiology of Alzheimer's disease. Expert Opinion on Therapeutic Targets 14:11, pages 1177-1197.
Read now
Read now
Articles from other publishers (79)
Sonia Singh, Ashima Ahuja, Himanshu Sharma & Pratik Maheshwari. (2023) An Overview of Dietary Flavonoids as a Nutraceutical Nanoformulation
Approach to Life-threatening Diseases. Current Pharmaceutical Biotechnology 24:14, pages 1740-1773.
Crossref
Crossref
Mater H. Mahnashi, Muhammad Ashraf, Abdulaziz Hassan Alhasaniah, Hammad Ullah, Alam Zeb, Mehreen Ghufran, Shah Fahad, Muhammad Ayaz & Maria Daglia. (2023) Polyphenol-enriched Desmodium elegans DC. ameliorate scopolamine-induced amnesia in animal model of Alzheimer’s disease: In Vitro, In Vivo and In Silico approaches. Biomedicine & Pharmacotherapy 165, pages 115144.
Crossref
Crossref
Ajit Thakur, Sunil Bogati & Sagar Pandey. (2023) Attempts to Develop Vaccines Against Alzheimer’s Disease: A Systematic Review of Ongoing and Completed Vaccination Trials in Humans. Cureus.
Crossref
Crossref
Anushree Chandrashekhar Gade, Manikanta Murahari, Parasuraman Pavadai & Maushmi Shailesh Kumar. (2023) Virtual Screening of a Marine Natural Product Database for In Silico Identification of a Potential Acetylcholinesterase Inhibitor. Life 13:6, pages 1298.
Crossref
Crossref
Agnieszka Zagórska, Anna Czopek, Monika Fryc, Anna Jaromin & Ben J. Boyd. (2023) Drug Discovery and Development Targeting Dementia. Pharmaceuticals 16:2, pages 151.
Crossref
Crossref
Yuanyuan Liang & Lin Wang. (2022) Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs. Journal of Ethnopharmacology 298, pages 115656.
Crossref
Crossref
Amarjitsing Rajput, Prashant Pingale & Vividha Dhapte-Pawar. (2022) Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Frontiers in Pharmacology 13.
Crossref
Crossref
Muhammad Ayaz, Asif Nawaz, Falak Naz, Farhat Ullah, Abdul Sadiq & Zia Ul Islam. (2022) Phytochemicals-based Therapeutics against Alzheimer's Disease: An Update. Current Topics in Medicinal Chemistry 22:22, pages 1811-1820.
Crossref
Crossref
Patrícia Moreira, Patrícia Matos, Artur Figueirinha, Lígia Salgueiro, Maria Teresa Batista, Pedro Costa Branco, Maria Teresa Cruz & Cláudia Fragão Pereira. (2022) Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences 23:15, pages 8812.
Crossref
Crossref
S. Sacco, S. Falquero, C. Bouis, M. Akkaya, J. Gallard, A. Pichot, G. Radice, F. Bazin, F. Montestruc, A. Hiance‐Delahaye & A.‐S. Rebillat. (2022) Modified cued recall test in the French population with Down syndrome: A retrospective medical records analysis. Journal of Intellectual Disability Research 66:8-9, pages 690-703.
Crossref
Crossref
Ahmed Morsy, Krishnaiah Maddeboina, Ju Gao, Hezhen Wang, Juan Valdez, Louise F. Dow, Xinglong Wang & Paul C. Trippier. (2022) Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction. ACS Chemical Neuroscience 13:14, pages 2176-2190.
Crossref
Crossref
Iohanan Daniel García Marín, Raúl Horacio Camarillo López, Oscar Aurelio Martínez, Itzia Irene Padilla-Martínez, José Correa-Basurto & Martha Cecilia Rosales-Hernández. (2022) New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease. PLOS ONE 17:6, pages e0269129.
Crossref
Crossref
Min He, Meiyan Fan, Zhiyun Peng & Guangcheng Wang. (2021) An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery. European Journal of Medicinal Chemistry 221, pages 113546.
Crossref
Crossref
Christian Griñán-Ferré, Aina Bellver-Sanchis, Vanessa Izquierdo, Rubén Corpas, Joan Roig-Soriano, Miguel Chillón, Cristina Andres-Lacueva, Milán Somogyvári, Csaba Sőti, Coral Sanfeliu & Mercè Pallàs. (2021) The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy. Ageing Research Reviews 67, pages 101271.
Crossref
Crossref
Natália F.F. Pirolla, Victor S. Batista, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Caitlin R. McCarthy, Claudio Viegas & Nailton M. Nascimento-Júnior. (2021) Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches. Current Drug Targets 22:5, pages 505-538.
Crossref
Crossref
Ke Wang, Liu Na & Mojie Duan. (2021) The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β. Current Topics in Medicinal Chemistry 21:2, pages 151-167.
Crossref
Crossref
Nima Sepehri, Maryam Mohammadi‐Khanaposhtani, Nafise Asemanipoor, Samanesadat Hosseini, Mahmood Biglar, Bagher Larijani, Mohammad Mahdavi, Haleh Hamedifar, Parham Taslimi, Nastaran Sadeghian & Ilhami Gulcin. (2020) Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives. Archiv der Pharmazie 353:10.
Crossref
Crossref
Fawzi Mahomoodally, Hassan H. Abdallah, Shanoo Suroowan, Sharmeen Jugreet, Yansheng Zhang & Xuebo Hu. (2020) In silico Exploration of Bioactive Phytochemicals Against Neurodegenerative Diseases Via Inhibition of Cholinesterases. Current Pharmaceutical Design 26:33, pages 4151-4162.
Crossref
Crossref
Beril Kadıoğlu Yaman, Özge Çevik, Kübra Yalman, Büşra Ertaş, Ali Şen & Göksel Şener. (2020) Myrtus communis subsp. communis improved cognitive functions in ovariectomized diabetic rats. Gene 744, pages 144616.
Crossref
Crossref
Júlia Companys-Alemany, Andreea L. Turcu, Aina Bellver-Sanchis, Maria I Loza, José M. Brea, Anna M Canudas, Rosana Leiva, Santiago Vázquez, Mercè Pallàs & Christian Griñán-Ferré. (2020) A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice. Pharmaceutics 12:3, pages 284.
Crossref
Crossref
Denglei Ma, Yi Luo, Rui Huang, Zirun Zhao, Qi Wang, Lin Li & Lan Zhang. (2020) Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A. Current Alzheimer Research 16:14, pages 1316-1331.
Crossref
Crossref
Jiayang Xie, Ruirui Liang, Yajiang Wang, Junyi Huang, Xin Cao & Bing Niu. (2020) Progress in Target Drug Molecules for Alzheimer's Disease. Current Topics in Medicinal Chemistry 20:1, pages 4-36.
Crossref
Crossref
Yong Qi Leong, Khuen Yen Ng, Soi Moi Chye, Anna Pick Kiong Ling & Rhun Yian Koh. (2019) Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metabolic Brain Disease 35:1, pages 11-30.
Crossref
Crossref
Jéssika P. Teixeira, Alexandre A. de Castro, Flávia V. Soares, Elaine F. F. da Cunha & Teodorico C. Ramalho. (2019) Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the Oxidative Stress Hypothesis. Molecules 24:23, pages 4410.
Crossref
Crossref
Eva Mezeiova, Katarina Chalupova, Eugenie Nepovimova, Lukas Gorecki, Lukas Prchal, David Malinak, Kamil Kuca, Ondrej Soukup & Jan Korabecny. (2019) Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. Current Alzheimer Research 16:9, pages 772-800.
Crossref
Crossref
Sudip Dhakal, Naufal Kushairi, Chia Wei Phan, Benu Adhikari, Vikineswary Sabaratnam & Ian Macreadie. (2019) Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease. International Journal of Molecular Sciences 20:20, pages 5090.
Crossref
Crossref
Richa Arya, Satya Prakash Gupta, Sarvesh Paliwal, Swapnil Sharma, Kirtika Madan & Monika Chauhan. (2019) Pharmacophore Modeling and Docking Studies to Investigate Potential Leads for the Development of β -Secretase APP Cleavage Enzyme-1 (BACE-1) Inhibitors. Letters in Drug Design & Discovery 16:7, pages 775-784.
Crossref
Crossref
Muhammad Ayaz, Abdul Sadiq, Muhammad Junaid, Farhat Ullah, Muhammad Ovais, Ikram Ullah, Jawad Ahmed & Muhammad Shahid. (2019) Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Jun Yuan, Bruno P. Meloni, Tianxing Shi, Anne Bonser, John M. Papadimitriou, Frank L. Mastaglia, Changqing Zhang, Minghao Zheng & Junjie Gao. (2019) The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer’s Disease. Journal of Alzheimer's Disease 69:1, pages 59-70.
Crossref
Crossref
Aparna Lakshmi Manchikalapudi, Rajasekhar Reddy Chilakala, Kiran Kalia & Aditya Sunkaria. (2019) Evaluating the Role of Microglial Cells in Clearance of Aβ from Alzheimer’s Brain. ACS Chemical Neuroscience 10:3, pages 1149-1156.
Crossref
Crossref
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, Prabhash Nath Tripathi, Anupam G. Banerjee & Sushant K. Shrivastava. (2019) Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. Progress in Neurobiology 174, pages 53-89.
Crossref
Crossref
Sushant K. Shrivastava, Saurabh K. Sinha, Pavan Srivastava, Prabhash N. Tripathi, Piyoosh Sharma, Manish K. Tripathi, Avanish Tripathi, Priyanka K. Choubey, Digambar K. Waiker, Lalit M. Aggarwal, Manish Dixit, Subhash C. Kheruka, Sanjay Gambhir, Sharmila Shankar & Rakesh K. Srivastava. (2019) Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer’s disease. Bioorganic Chemistry 82, pages 211-223.
Crossref
Crossref
Jahangir Alam & Lalit Sharma. (2019) Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review. Current Drug Targets 20:3, pages 316-339.
Crossref
Crossref
Gang Cheng, Ping Xu, Minkui Zhang, Jing Chen, Rong Sheng & Yongmin Ma. (2018) Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer’s disease. Bioorganic & Medicinal Chemistry 26:22, pages 5759-5765.
Crossref
Crossref
Sanhita Maity, Sampa Pal, Subrata Sardar, Nayim Sepay, Hasan Parvej, Shahnaz Begum, Ramkrishna Dalui, Niloy Das, Anirban Pradhan & Umesh Chandra Halder. (2018) Inhibition of amyloid fibril formation of β-lactoglobulin by natural and synthetic curcuminoids. New Journal of Chemistry 42:23, pages 19260-19271.
Crossref
Crossref
Theodora Panagaki, Simon Gengler & Christian Hölscher. (2018) The Novel DA–CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model. Journal of Alzheimer's Disease 66:1, pages 195-218.
Crossref
Crossref
Vivitri Prasasty, Muhammad Radifar & Enade Istyastono. (2018) Natural Peptides in Drug Discovery Targeting Acetylcholinesterase. Molecules 23:9, pages 2344.
Crossref
Crossref
Nina Chufarova, Kamila Czarnecka, Robert Skibiński, Magda Cuchra, Ireneusz Majsterek & Paweł Szymański. (2018) New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease. Archiv der Pharmazie 351:7, pages 1800050.
Crossref
Crossref
Etienne Croteau, Christian-Alexandre Castellano, Marie Anne Richard, Mélanie Fortier, Scott Nugent, Martin Lepage, Simon Duchesne, Kevin Whittingstall, Éric E. Turcotte, Christian Bocti, Tamàs Fülöp & Stephen C. Cunnane. (2018) Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease. Journal of Alzheimer's Disease 64:2, pages 551-561.
Crossref
Crossref
Sukesh Kumar Gupta, Manoj Kumar Mesharam & Sairam Krishnamurthy. (2018) Electromagnetic radiation 2450 MHz exposure causes cognition deficit with mitochondrial dysfunction and activation of intrinsic pathway of apoptosis in rats. Journal of Biosciences 43:2, pages 263-276.
Crossref
Crossref
Sotirios Katsamakas & Dimitra Hadjipavlou-Litina. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches
203
253
.
Youssef Dgachi, Helène Martin, Alexandre Bonet, Mourad Chioua, Isabel Iriepa, Ignacio Moraleda, Fakher Chabchoub, José Marco-Contelles & Lhassane Ismaili. (2017) Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy. Future Medicinal Chemistry 9:8, pages 715-721.
Crossref
Crossref
Udo Rüb, Katharina Stratmann, Helmut Heinsen, Kay Seidel, Mohamed Bouzrou & Horst-Werner Korf. (2017) Alzheimer’s Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches. Journal of Alzheimer's Disease 57:3, pages 683-696.
Crossref
Crossref
Inês Cruz, Ploenthip Puthongking, Sara Cravo, Andreia Palmeira, Honorina Cidade, Madalena Pinto & Emília Sousa. (2017) Xanthone and Flavone Derivatives as Dual Agents with Acetylcholinesterase Inhibition and Antioxidant Activity as Potential Anti-Alzheimer Agents. Journal of Chemistry 2017, pages 1-16.
Crossref
Crossref
Akhlaq A. Farooqui. 2017. Neurochemical Aspects of Alzheimer's Disease. Neurochemical Aspects of Alzheimer's Disease
331
359
.
Kazuma Murakami, Maki Tokuda, Takashi Suzuki, Yumi Irie, Mizuho Hanaki, Naotaka Izuo, Yoko Monobe, Ken-ichi Akagi, Ryotaro Ishii, Harutsugu Tatebe, Takahiko Tokuda, Masahiro Maeda, Toshiaki Kume, Takahiko Shimizu & Kazuhiro Irie. (2016) Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis. Scientific Reports 6:1.
Crossref
Crossref
Houssem Boulebd, Lhassane Ismaili, Manuela Bartolini, Abdelmalek Bouraiou, Vincenza Andrisano, Helene Martin, Alexandre Bonet, Ignacio Moraleda, Isabel Iriepa, Mourad Chioua, Ali Belfaitah & José Marco-Contelles. (2016) Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy. Molecules 21:4, pages 400.
Crossref
Crossref
Rita Maria Concetta Di Martino, Angela De Simone, Vincenza Andrisano, Paola Bisignano, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Romana Fato, Christian Bergamini, Daniel I. Perez, Ana Martinez, Giovanni Bottegoni, Andrea Cavalli & Federica Belluti. (2016) Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors. Journal of Medicinal Chemistry 59:2, pages 531-544.
Crossref
Crossref
Rong Sheng, Li Tang, Liu Jiang, Lingjuan Hong, Ying Shi, Naiming Zhou & Yongzhou Hu. (2015) Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease. ACS Chemical Neuroscience 7:1, pages 69-81.
Crossref
Crossref
Liu Jiang, Minkui Zhang, Li Tang, Qinjie Weng, Yanhong Shen, Yongzhou Hu & Rong Sheng. (2016) Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy. RSC Advances 6:21, pages 17318-17327.
Crossref
Crossref
Mourad Chioua, Javier Pérez-Peña, Nuria García-Font, Ignacio Moraleda, Isabel Iriepa, Elena Soriano, José Marco-Contelles & María Jesús Oset-Gasque. (2015) Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease. Future Medicinal Chemistry 7:7, pages 845-855.
Crossref
Crossref
Michael G Kallitsakis, Matilde Yañez, Elena Soriano, José Marco-Contelles, Dimitra J Hadjipavlou-Litina & Konstantinos E Litinas. (2015)
Purine homo
-N
-nucleoside+coumarin hybrids as pleiotropic agents for the potential treatment of Alzheimer's disease
. Future Medicinal Chemistry 7:2, pages 103-110.
Crossref
Crossref
Mohamed Benchekroun, Lhassane Ismaili, Marc Pudlo, Vincent Luzet, Tijani Gharbi, Bernard Refouvelet & José Marco-Contelles. (2015) Donepezil–ferulic acid hybrids as anti-Alzheimer drugs. Future Medicinal Chemistry 7:1, pages 15-21.
Crossref
Crossref
Oussama Cherif, Fatma Allouche, Fakher Chabchoub, Mourad Chioua, Elena Soriano, Matilde Yañez, Ramón Cacabelos, Alejandro RomeroManuela G López & Jose Marco-Contelles. (2014) Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease. Future Medicinal Chemistry 6:17, pages 1883-1891.
Crossref
Crossref
Thomas Wisniewski & Fernando Goñi. (2014) Immunotherapy for Alzheimer's disease. Biochemical Pharmacology 88:4, pages 499-507.
Crossref
Crossref
Sun-Ho HanInhee Mook-Jung. (2014) Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease. Journal of Korean Medical Science 29:7, pages 893.
Crossref
Crossref
Ramón Cacabelos, Pablo Cacabelos & Clara Torrellas. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
563
615
.
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
323
556
.
Fernando Goñi, Krystal Herline, Daniel Peyser, Kinlung Wong, Yong Ji, Yanjie Sun, Pankaj Mehta & Thomas Wisniewski. (2013) Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models. Journal of Neuroinflammation 10:1.
Crossref
Crossref
Christian Bleiholder, Thanh D. Do, Chun Wu, Nicholas J. Economou, Summer S. Bernstein, Steven K. Buratto, Joan-Emma Shea & Michael T. Bowers. (2013)
Ion Mobility Spectrometry Reveals the Mechanism of Amyloid Formation of Aβ(25–35) and Its Modulation by Inhibitors at the Molecular Level: Epigallocatechin Gallate and
Scyllo
-inositol
. Journal of the American Chemical Society 135:45, pages 16926-16937.
Crossref
Crossref
Mizuho Sato, Kazuma Murakami, Mayumi Uno, Yu Nakagawa, Sumie Katayama, Ken-ichi Akagi, Yuichi Masuda, Kiyonori Takegoshi & Kazuhiro Irie. (2013) Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues. Journal of Biological Chemistry 288:32, pages 23212-23224.
Crossref
Crossref
Li-Li Guo, Zhi-Zhong Guan, Yong Huang, Yong-Lin Wang & Jin-Shan Shi. (2013) The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. Experimental and Toxicologic Pathology 65:5, pages 579-584.
Crossref
Crossref
Philippe Monnier, Robin Vigouroux & Nardos Tassew. (2013) In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2:4, pages 193-208.
Crossref
Crossref
Colleen E. Jackson, Paul T. Maruff & Peter J. Snyder. (2012) Massed versus spaced visuospatial memory in cognitively healthy young and older adults. Alzheimer's & Dementia 9:1S.
Crossref
Crossref
Junling Yang, Abhinandan Pattanayak, Min Song, Jinghong Kou, Hiroaki Taguchi, Sudhir Paul, Selvarangan Ponnazhagan, Robert Lalonde & Ken-ichiro Fukuchi. (2012) Muscle-Directed Anti-Aβ Single-Chain Antibody Delivery via AAV1 Reduces Cerebral Aβ Load in an Alzheimer’s Disease Mouse Model. Journal of Molecular Neuroscience 49:2, pages 277-288.
Crossref
Crossref
Joanna L. Richens, Bharak Vafadar-Isfahani, Kelly-Ann Vere, Graham Ball, Noor Kalsheker, Robert Rees, Nin Bajaj, Paul O’Shea & Kevin Morgan. 2013. Genetic Variants in Alzheimer's Disease. Genetic Variants in Alzheimer's Disease
231
248
.
Tetsuya Asakawa & Ying Xia. 2013. Current Research in Acupuncture. Current Research in Acupuncture
255
301
.
Simon J Hughes. (2012) Nuclear medicine functional imaging of the brain. Clinical Medicine 12:4, pages 364-368.
Crossref
Crossref
Marek Bajda, Kamil J. Kuder, Dorota Łażewska, Katarzyna Kieć‐Kononowicz, Anna Więckowska, Michalina Ignasik, Natalia Guzior, Jakub Jończyk & Barbara Malawska. (2012)
Dual‐Acting Diether Derivatives of Piperidine and Homopiperidine with Histamine H
3
Receptor Antagonistic and Anticholinesterase Activity
. Archiv der Pharmazie 345:8, pages 591-597.
Crossref
Crossref
Thomas Wisniewski. (2012) Active immunotherapy for Alzheimer's disease. The Lancet Neurology 11:7, pages 571-572.
Crossref
Crossref
Sharmistha Sinha, Zhenming Du, Panchanan Maiti, Frank-Gerrit Klärner, Thomas Schrader, Chunyu Wang & Gal Bitan. (2012)
Comparison of Three Amyloid Assembly Inhibitors: The Sugar
scyllo-
Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
. ACS Chemical Neuroscience 3:6, pages 451-458.
Crossref
Crossref
Francesco PanzaVincenza Frisardi, Vincenzo Solfrizzi, Bruno P Imbimbo, Giancarlo Logroscino, Andrea Santamato, Antonio Greco, Davide Seripa & Alberto Pilotto. (2012) Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy 4:2, pages 213-238.
Crossref
Crossref
Jennifer D. Lanning & Stephen C. Meredith. 2012. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases
433
560
.
Paul J. Barrett, Charles R. Sanders, Stephen A. Kaufman, Klaus Michelsen & John B. Jordan. (2011) NSAID-Based γ-Secretase Modulators Do Not Bind to the Amyloid-β Polypeptide. Biochemistry 50:47, pages 10328-10342.
Crossref
Crossref
Antoine Lampron, David Gosselin & Serge Rivest. (2011) Targeting the hematopoietic system for the treatment of Alzheimer’s disease. Brain, Behavior, and Immunity 25, pages S71-S79.
Crossref
Crossref
Wassilios G. Meissner, Mark Frasier, Thomas Gasser, Christopher G. Goetz, Andres Lozano, Paola Piccini, José A. Obeso, Olivier Rascol, Anthony Schapira, Valerie Voon, David M. Weiner, François Tison & Erwan Bezard. (2011) Priorities in Parkinson's disease research. Nature Reviews Drug Discovery 10:5, pages 377-393.
Crossref
Crossref
. (2010) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 25:12.
Crossref
Crossref
M D Carter, G A Simms & D F Weaver. (2010) The Development of New Therapeutics for Alzheimer's Disease. Clinical Pharmacology & Therapeutics 88:4, pages 475-486.
Crossref
Crossref
Akiko Kasai. (2010) The Increase of D-Amino Acids in Alzheimer′s Disease-Related Proteins Isolated from the Brains of SAMP8 Mice. Journal of The Society of Japanese Women Scientists 11:1, pages 57-64.
Crossref
Crossref